Vitor Alves Cruz, Camila Guimarães, Jozelia Rêgo, Ketty Lysie Libardi Lira Machado, Samira Tatiyama Miyamoto, Ana Paula Neves Burian, Laiza Hombre Dias, Flavia Zon Pretti, Danielle Cristina Filgueira Alves Batista, José Geraldo Mill, Yasmin Gurtler Pinheiro de Oliveira, Carolina Strauss Estevez Gadelha, Maria da Penha Gomes Gouveia, Anna Carolina Simões Moulin, Bárbara Oliveira Souza, Laura Gonçalves Rodrigues Aguiar, Gabriel Smith Sobral Vieira, Luiza Lorenzoni Grillo, Marina Deorce de Lima, Laís Pizzol Pasti, Heitor Filipe Surlo, Filipe Faé, Isac Ribeiro Moulaz, Mariana de Oliveira Macabú, Priscila Dias Cardoso Ribeiro, Vanessa de Oliveira Magalhães, Mariana Freitas de Aguiar, Erika Biegelmeyer, Flávia Maria Matos Melo Campos Peixoto, Cristiane Kayser, Alexandre Wagner Silva de Souza, Charlles Heldan de Moura Castro, Sandra Lúcia Euzébio Ribeiro, Camila Maria Paiva França Telles, Juliana Bühring, Raquel Lima de Lima, Sérgio Henrique Oliveira Dos Santos, Samuel Elias Basualto Dias, Natália Seixas de Melo, Rosely Holanda da Silva Sanches, Antonio Luiz Boechat, Natália Sarzi Sartori, Vanessa Hax, Lucas Denardi Dória, Rodrigo Poubel Vieira de Rezende, Katia Lino Baptista, Natália Rodrigues Querido Fortes, Ana Karla Guedes de Melo, Tâmara Santos Melo, Rejane Maria Rodrigues de Abreu Vieira, Adah Sophia Rodrigues Vieira, Adriana Maria Kakehasi, Anna Carolina Faria Moreira Gomes Tavares, Aline Teixeira de Landa, Pollyana Vitoria Thomaz da Costa, Valderilio Feijó Azevedo, Olindo Assis Martins-Filho, Vanessa Peruhype-Magalhães, Marcelo de Medeiros Pinheiro, Odirlei André Monticielo, Edgard Torres Dos Reis-Neto, Gilda Aparecida Ferreira, Viviane Angelina de Souza, Andréa Teixeira-Carvalho, Ricardo Machado Xavier, Emilia Inoue Sato, Valeria Valim, Gecilmara Salviato Pileggi, Nilzio Antonio da Silva
BACKGROUND: Patients with immune-mediated rheumatic diseases (IMRDs) have been prioritized for COVID-19 vaccination to mitigate the infection severity risks. Patients with rheumatoid arthritis (RA) are at a high risk of severe COVID-19 outcomes, especially those under immunosuppression or with associated comorbidities. However, few studies have assessed the safety of the COVID-19 vaccine in patients with RA. OBJECTIVE: To evaluate the safety of vaccines against SARS-CoV-2 in patients with RA...
August 12, 2024: Advances in Rheumatology